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Objectives: To determine treatment compliance and how compliance was perceived by patients, parents and by a multidisciplinary team in Cystic
Fibrosis (CF) patients. Also to analyse the relative importance given to each of the prescribed treatments, reasons for non-adherence and to
investigate possible predictors of therapeutic compliance.
Patients and methods: 34 CF patients (21 females), aged between 1.6 and 40.6 years, attending an outpatient CF clinic. Design: cross-sectional. A
self-administered questionnaire was given to all patients whilst attending a programmed visit which was used to determine compliance to different
treatments (physiotherapy, nutritional supplements, respiratory and digestive medications). Patients were subjectively classified as compliant or
non-compliant by medical staff involved in their care.
Results: Treatment compliance was greater for digestive (88.2%) and respiratory medication (61.8%), compared to physiotherapy (41.2%) or
nutritional supplements (59%). CF patients considered digestive medication indispensable (94.1%), compared to nutritional supplements
(44.1%). Whilst 26.4% of CF patients considered that respiratory medications or nutritional supplements influenced little or nothing in their
quality of life. Comparing age groups younger patients were found to be more compliant (10.4 vs. 20.5 years p=0.008) and had less severe
disease (Shwachman score 83.2 vs. 73.9 p=0.048).
Conclusions: CF patients had greater treatment adherence when prescribed digestive and respiratory medications, compared to physiotherapy or
nutritional supplements. Therapeutic adherence was found to worsen with age and disease severity, however improved with treatments which were
perceived by patients as more important or had a greater influence in their quality of life.
© 2008 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.Keywords: Compliance; Treatment adherence; Cystic Fibrosis; Children with CF1. Introduction
Cystic Fibrosis (CF) is the most common fatal inherited
disease affecting Caucasians [1]. Over the last few years,
survival of CF patients has increased markedly. This being
attributed to an earlier diagnosis of the disease [2], patient care⁎ Corresponding author. Department of Pediatrics, Hospital Universitario
Central de Asturias, C/ Celestino Villamil s/n, 33006, Oviedo, Asturias, Spain.
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1569-1993/$ - see front matter © 2008 European Cystic Fibrosis Society. Publishe
doi:10.1016/j.jcf.2008.01.003improvement involving multidisciplinary teams, and more
effective therapeutic options [3–5].
Many CF patients require continuous care at home with many
prophylactic medications as nebulised or oral antibiotics, pan-
creatic enzymes, mucolytic agents, vitamin or nutritional sup-
plements, as well as daily physiotherapy, and a healthy lifestyle
with adequate nutrition and exercise. Those treatments intensify
and get more complicated during disease exacerbations. The
life-long duration of the treatment and complexity itself of CF
treatments, have been pointed as main determinants of thera-
peutic adherence. Several studies indicate a 30–70% therapeutic
adherence in CF [3,5–7], similar to other chronic diseases [5].
Previous research indicates that patient with CF adhere more to
some treatment components than others, observing a complianced by Elsevier B.V. All rights reserved.
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whilst compliance was higher with enzyme regimens (65–95%)
and antibiotics (70–90%) [3,4,6]. In children with CF the overall
adherence is about 50% [8].
There are several factors to be taken into account as pos-
sible predictors of adherence in CF, with contradictory results
[3–5,7,9–13]: Demographic data (sex, age, education level,
socio-economic status, socio-familial relations, profession),
clinical factors (age at diagnosis, severity of CF, after lung
transplantation [10,14,15] and another factor could be the
transfer from paediatricians to adult medical staff, the knowl-
edge about their illness or the different ways of coping with
CF [9]. An irregular therapeutic adherence in CF patients may
worsen their disease. The knowledge of the different aspects
that leads a patient to complain to different treatments and the
reasons given by the patients to justify incompliance, may
help the practitioners dealing with these patients in order to
improve therapeutic adherence among their patients and to
influence disease progression.
The objectives of our study include various aspects. An es-
timation of patient compliance with regards to physiotherapy,
nutritional supplements, respiratory and digestive medications.
Also analysed was the perceptions among patients and a multi-
disciplinary team, including the relative importance given to each
of the prescribed treatments. We also investigated the reasons for
non-adherence, so as to determine possible predictors of thera-
peutic compliance.
2. Patients and methods
2.1. Patients
Thirty-four CF patients attending trimester revisions in an
outpatient CF clinic managed by paediatric gastroenterologists
and pneumologists at the University Hospital Central de As-
turias. Until the age of 14 (younger than 15 years) they are
controlled by pediatric gastroenterologists and pneumologists
and by an adult specialist from that age on.
2.2. Study protocol
Data was collected reviewing patient clinical histories, an-
alysing epidemiologic data (age, gender, age onset diagnosisTable 1
Impact of treatment on patient's quality of life
Much Som
Physiotherapy 35.2% 17.6
(25–45) (5–3
Respiratory 26.5% 29.4
(11–41) (14–
Digestive 38.2% 44.1
(20–52) (27–
Nutritional 11.7% 38.2
(3–28) (20–
95% Confidence interval limits in brackets.of CF, period of evolution, CFTR mutation), respiratory
evaluation (treatment received at the time of the interview,
spirometric values, Bhalla score, lung transplantation), diges-
tive evaluation (body mass index (BMI); nutritional index (NI);
serum levels of alkaline phosphatase, transaminases, gamma-
glutamyl transpeptidase, fat soluble vitamins, folic acid, albu-
min, β-carotene, fecal elastase, and immunoreactive trypsin
(IRT); 72-hour fecal fat excretion) and a global evaluation
(associated co-morbidities, Shwachman–Kulczycki score).
2.3. Questionnaire
A self-administered questionnaire was given to each patient
while attending a routinary appointment in our outpatient clinic.
Patients aged older than 12 years completed the questionnaire
themselves, while it was fulfilled by their parents when younger.
The questionnaire included four sections, each section in relation
with the different treatments given to the CF patients: physio-
therapy, respiratory medication (including DNase, antibiotics,
and inhaled corticosteroids), digestive medication (including pan-
creatic enzymes, vitamins, deoxycholic acid, and antacids) and
nutritional supplements.
In each section, CF patients were asked multiple questions
on treatment compliance, frequency of treatment, importance
given to the treatment, patient's own opinion about their
compliance and reasons for non-compliance. At the end of
the questionnaire CF patients were scored from 0 to 100%
considering all treatments received, according to their global
therapeutic compliance.
Each item of the four different subsets of questions, except
from the patient reasons for non-compliance and the patient's
opinion about self therapeutic compliance, were scored, with a
maximum score of 8 points for each subset. A CF patient was
considered compliant for any of the treatments if the score ob-
tained is equal or higher than 4. If the global score, obtained
by adding all the partial scores, is equal or higher than 8, the
CF patient is considered globally compliant. Patients were
then grouped in compliant and non-compliant for each of the
therapeutic options and globally. Also a paediatric and adult
gastroenterologist, pneumologist and nurse specialist involved
in the CF clinic were also asked to classify subjectively CF
patients in compliant and non-compliant according to treatment
compliance.e Little Nothing
% 17.6% 29.4%
1) (5–31) (14–44)
% 11.7% 14.7%
44) (3–28%) (3–27)
% 2.9% 8.8%
61) (0.08–17) (2–27)
% 11.7% 14.7%
52) (3–28%) (3–27)
Table 2
Reasons for the poor compliance with different treatments
Predominant reasons for poor compliance n (% patients)
Physiotherapy
Not enough time 8 (29.4)
I don't think I need it, I feel well without treatment 7 (20.6)
Exercise instead 7 (20.6)
I believe that doing it I don't feel better 5 (14.7)
It interferes with my social life 4 (11.7)
I simply forget it 3 (8.8)
Transplantation 2 (5.9)
Respiratory medication
I don't think I need it 4 (11.7)
Not enough time 3 (8.8)
Only when I feel worse 3 (8.8)
It interferes with my social life 2 (5.9)
I simply forget it 2 (5.9)
Digestive medication
I simply forget it 2 (5.9)
Nutritional supplements
I don't think I need it 5 (14.7)
I don't like the taste or texture 5 (14.7)
I simply forget it 3 (8.8)
I don't believe in it 2 (5.9)
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Data was analysed using a statistical program (SPSS 11.0).
Results are expressed as mean and standard deviation or range
for quantitative variables, and as proportions for qualitative
variables. Chi-square test and Fisher´s exact test were used
to compare proportions, and Student's t test to compare means.
If the variable was significantly different from normality
(using the Shapiro–Wilk's test) Mann–Whitney's U test
was used instead. A p valueb0.05 was deemed statistically
significant.
3. Results
3.1. Demographic and clinical variables
Thirty-four CF patients (21 female) with an age range of 1.6
to 40.6 years (mean 14.5) were included in the study. Fourteen
patients were under 10 years of age, 11 between 10 and 20, and 9
were aged over 20. The average time of evolution of the diseaseFig. 1. Percentage of therapeutic adherence for each type of twas 12.2 years (range from 1.3 to 40.6).Mean spirometric values
were within the normal range: VC 89% (range from 57–125% of
predicted values) and FEV1 79% (range from 36–118%). A
mean Bhalla score of 5.04 was observed (SD 3.5). Four CF
patients were carriers of a double lung transplantation. The
ΔF508 mutation was present in 73.53% of the CF patients.
Fat-soluble vitamins were within the normal range, although
β-carotene levels were far below those considered normal (mean
67.3 mcg/l, range 20–189 mcg/l). All CF patients showed
pancreatic insufficiency, with fecal elastase values lower than
25 mcg/g, except for one patient which had a fecal elastase value
of 413 mcg/g. All CF patients showed excessive faecal fat loss
(mean 10%, range 6.3–15.2%). Although mean IRT values were
normal, 18 patients showed IRT values lower than 10 ng/ml.
According to anthropometrics values, CF patients had on
average a normal nutritional status (mean NI 93.6%), but ranged
from undernutrition to overweight (NI 74.4–116%).
3.2. Degree of compliance
Fifty percent of CF patients showed daily compliance for
respiratory medication and nutritional supplements, compared to
only 38% compliance for physiotherapy (17.6% 3 to 5 times a
week). Findings included that 20.6% of CF patients never
practiced physiotherapy, 5.8% never took their respiratory
medications, and 29.4% of CF patients never consumed their
nutritional supplements.Additionally, 14.7%of patients only took
their respiratory medications when they felt worse, 6% practice
then physiotherapy and, 2.9% took their nutritional supplements.
On the other hand, 100% of CF patients took their digestive
medications daily, although 64.7% admitted that they only
consumed pancreatic enzymes with their main meals and not
during snacks. Accordingly, 94.1% of CF patients, recognized
digestive medication as essential, while percentages were lower
for respiratory medications, physiotherapy and nutritional sup-
plements (70.6%, 59% and 44.1% respectively).
3.3. Importance given to different types of treatment and
patient's perception of compliance
CF patients evaluated the different therapeutic options on a
scale from 1 to 10. The following results were obtained: diges-
tive medication 9.4, respiratory medication 8.0, physiotherapy
7.2, and nutritional supplements 6.2. Patient satisfaction aboutreatment based on questionnaire and specialist opinions.
Table 3
Age, gender, disease severity and time of evolution in CF patients
Compliant Non-compliant P
Mean (SD) Mean (SD)
Age(years) 10.4 (6.1) 20.5 (10.8) 0.008
Disease evolution(years) 9.5 (6.2) 16.9 (11) 0.025
Severity(Shwachman score) 83.2 (6) 73.9 (15) 0.048
Table 4
Importance given to the different therapeutic options by CF patients
Compliant Non-compliant P
Mean (SD) Mean (SD)
Physiotherapy 9.5 (2) 5 (0.7) 0.000
Respiratory 8.8 (1.5) 6.4 (3) 0.010
Digestive 9.7 (0.7) 7 (1.7) 0.001
Nutritional 8.6 (1.4) 4.3 (3.1) 0.000
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a 70.6% of the CF patients considered that they were taking the
correct dose of digestive medication, whilst only 8.8%
considered that they should have been more compliant. On the
other hand, only 29.4% of CF patients considered that they were
practicing as much physiotherapy as needed, in comparison to
41.2% which thought that they should practice more frequently.
Also evaluated was patient's perception with respect to their
quality of life obtained as a result of following medical treat-
ment (Table 1). While nearly 90% of the patients thought that
digestive medication significantly improved their quality of
life, only half of the CF patients considered that physiotherapy
played little or no role.
Overall with regards to taking medication patients thought
they were compliant in 84.8%.Table 5
Biochemical and anthropometric nutritional parameters, pancreatic function and spy
Compliant
Mean±SD
Vitamin A (mg/l) 0.55±0.3
Vitamin K (mcg/l) 2.2±8.6
Vitamin D (ng/l) 32.7±13.4
Vitamin E (mcg/ml) 19±2.8
Folic acid (ng/ml) 9.6±4.4
Albumin (g/l) 43.3±4.3
β-carotene (mcg/l) 76.7±52
BMI (Kg/m2) 17.7±2.5
NI(%) 95±10.5
Fecal fat (%) 10.1±2.5
VC (%) 89.50±17.3
FEV1 (%) 79.71±22.1
FEF25–75 (%) 85.79±24.4
BMI: body mass index. VC: vital capacity. NI: nutritional index. FEV1: forced exp
middle portion of the expiration.3.4. Reasons for poor compliance
The main reason given for not taking digestive medications
was forgetfulness. Some patients considered that they did not
need the medication at all, in particular with respiratory medi-
cation and nutritional supplements, 11.7% and 14.7% respec-
tively. An additional 8.8% argued that they did not have time to
take their respiratory medications, while 14.7% argued a bad
flavour or texture as an excuse for not taking their nutritional
supplements (Table 2).
Reasons given for not doing their physiotherapy exercises
included not having enough time (23.5%), no need for treatment
(20.6%), and substitution by other exercises (20.6%). A
significant fall in physiotherapy compliance was observed after
lung transplant (Table 2).rometric values in CF patients
Non-compliant P
Mean±SD
0.47±0.2 0.61
0.2±0.1 0.77
34.8±19.6 0.95
8.3±3.7 0.64
11.8±9 0.71
41.4±2.1 0.005
46±30 0.09
18.97±3.2 0.17
90±11.6 0.39
9.85±2.6 0.85
88.55±16.1 0.67
78.10±18.6 0.73
64.48±44.9 0.09
iratory volume in the first second. FEF25–75: forced expiratory flow during the
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patients
Patients were grouped into compliant and non-compliant
according to each type of treatment and globally in two ways,
based on their questionnaire scores and based on the opinion of
the multidisciplinary team. Fig. 1 shows percentage of adhe-
rence for each type of treatment. Questionnaire results showed a
global compliance of 59%, and only 56% were compliant based
upon the opinion of a clinician.
Non-compliant patients were significantly older, had longer
time of evolution of their disease and a more severe disease
(Table 3). We have observed that 23.8% of patients younger
than 15 years were non-compliant, while this percentage rose to
69.2% in adolescents and adults (older than 15 years of age). No
gender differences were observed. Moreover, compliant CF
patients gave more importance to all of the different therapeutic
options than non-compliant CF patients (Table 4).
Nutritional parameters were also analysed, and compliant CF
showed significantly higher albumin values than non-compliant.
No differences were observed for any of the other biochemical
factors studied (Table 5). No age adjusted differences were
observed in BMI, (Table 5). No differences were observed for
fecal fat, NI, and spirometric values (Table 5).
4. Discussion
Preventive management and symptomatic treatment has
been instituted progressively at more early ages for CF
patients, developing as a daily concern for most patients with
CF [3]. So it has become an essential component of patients
care by health professionals to measure and promote adherence
to the various treatments that are needed throughout their lives.
In order to achieve this, it is important to explain and justify
clearly to patients any measure and to be alert to doubts arising
in patients.
There have been several studies that have previously
investigated differences in adherence with respect to different
components of treatment regimes in CF patients [3–8,16,17]. In
our study, patients seemed to consider essential both digestive
and respiratory medications, and thus a better compliance was
observed for these treatments, this has also been described by
other studies [3–6,9]. This could be explained by the short-term
benefits obtained and the early appearance of unpleasant
symptoms secondary to lack of adherence [4,6]. This reasoning
justifies the high compliance with regards to the consumption of
pancreatic enzymes in order to avoid steatorrhea.
For nutritional supplements and physiotherapy there are
several references that show a low grade of treatment adherence,
ranging between 40 and 55%. In comparison compliance in-
creases to 75–90% with antibiotics and pancreatic enzymes. In
our study the number of patients compliant with digestive med-
ication is similar to results shown elsewhere [3–6,9]. Of note
adherence with respiratory medication was lesser, however we
did not make a distinction between the different types of
respiratory medication. If we took into consideration the
individual adherence to bronchodilators, antibiotics or inhaledcorticosteroids, the adherence to treatment would probably have
been greater.
Furthermore, our patients show better compliance with those
treatments which they believe were more beneficial and had
more repercussion in their quality of life. Several previous
studies have demonstrated that those patients who realize the
importance of following medical instructions and trust their
physician are probably more compliant [5,9,18]. If physicians
are able to convince their patients of the importance of measures
taken this would positively influence their clinical evolution and
improve their quality of life, and so increased adherence would
be observed.
The data found concerning aspects of physiotherapy
reflected a clear deficiency. Generally few patients practiced
physiotherapy and the frequency with which they practiced was
far from ideal, a common finding in the literature [3–6,9,17].
The number of patients which practiced daily physiotherapy
reached only 30%, similar to other results in CF clinics [9,10].
It is of concern that only 59% of patients consider physiother-
apy as an essential part of their treatment, contrary to current
clinical belief. Many patients are sceptical as to the repercus-
sion on their quality of life, which is reflected by the different
importance given to physiotherapy by compliant and non-
compliant groups.
The main reasons given by patients for poor compliance are
lack of time, they don't need it or that they can substitute
physiotherapy by exercise. Of note is that the average time that
our patients spend practising physiotherapy was surprisingly
less, than the average time of evolution of the disease (7.6 vs.
12.2). The patients perception of having no beneficial effects
practising physiotherapy seemed to be an extended idea
[6,11,19,20], and it has also been published that patients
substitute exercise instead of physiotherapy in 20% of the cases
[5,6], such as we found.
In our study we have observed that treatment adherence
decreases with severity of CF disease. Other authors explain this
phenomena reasoning a lack of positive reinforcement when
patients do not note a beneficial effect with treatment compliance
[6,21]. However there are also other authors which describe the
opposite, with results relating disease severity with treatment
adherence [5,7,10,13].
The perception of disease severity is also different between
physician and patient. From the physician's viewpoint, patients
seem to underestimate the severity of the disease [5,6]. Therefore
only 70% of those patients who believe to be compliant,
according to the questionnaire results are also considered so by
their specialised doctors. Patients also overestimate their care, so
when they are asked how they think they fare in overall com-
pliance with relation to the medication prescribed, the results
express a better adherence (84.8%) than the results obtained by
the questionnaire score.
The fact that treatment adherence tends to diminish with age
has also been mentioned in previous studies [6,11,12]. In
childhood a high level of compliance is frequently observed,
probably explained by the role parents play at that age [22,23].
A good family cohesion and adequate social support has been
associated with better treatment adherence [7,9,14,22–24].
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coinciding with the progressive decrease in parent's super-
vision at a progressive older age, as we also found in our
study. In a study described in Montreal University about
treatment adherence in adolescents affected by chronic ill-
nesses, such as CF, a global adherence of 50% was estimated,
but only 11% of the subjects presented a good compliance to all
of the treatment components [7]. In another study at Mich-
igan University, regarding lipo-soluble vitamin intake in CF
patients [13], a significant statistical difference existed between
the group of patients aged younger than 12 years vs. older
patients.
In some adolescents their perception of their own illness
changes, in particular when they themselves become more
responsible for their own disease and treatment. The impor-
tance placed on their illness may relatively diminish due to the
increasing problems and challenges that arise at this moment in
their life. Some refer embarrassment in taking their treatment in
front of other people and so they tend to hide their illness
leading to statements such as “it interferes with my social life”
and “ I don't want my friends to know that I suffer fromCF” [4],
as we have confirmed in our work. Other reasons for decreased
compliance include the transfer of patient care from paedia-
tricians to adult medical staff [3,7], which may cause a lack of
confidence between patients and adult medical due to the new
relationship established.
Decrease in adherence occurs typically after lung transplan-
tation [9,14,15].Wemust emphasise that half of our transplanted
patients gave up physiotherapy techniques afterwards, reasoning
that they thought it was not necessary. Though its known that
medical opinions are against this attitude [3], there is actually a
recognised decrease in treatment adherence after lung trans-
plantation that seems to increase with time [9,14]. This may be
explained by their own better general well being and thus
reasoning that they don't need it anymore [14]. Thus it is
essential to inform patients carefully and to follow up with
adequate supervision to be able to reorient and help them
eradicate these wrong beliefs.
The results are in some way influenced by the strategies of
measurements employed [3,8,15] and the definition of
“treatment adherence ” adopted, so even with a significantly
lesser compliance than 100%, we may obtain a reasonable
level of health [3]. Nevertheless the cut-off point in which
objectively we could not obtain anymore favourable results
and must be urged to promote a greater compliance is very
difficult to define [25]. In our study even with a low grade
of adherence observed in general, 58.8% of the controlled
patients in our unit presented a good global prognostic score
according to the Shwachman–Kulczycki scale, and even
26.4% are qualified as excellent.
Although with better compliance we could also have
achieved lesser illness severity. On the other hand it is
important to decrease non-compliance, due to the fact that it
can damage our knowledge of the effectiveness of different
treatments, increase the number of outpatient visits and hospital
stays, modify the course of illness and increase health care
expenditures.We are aware that the results of our study are based on
subjective data obtained after a personal interview with parents
and/or patients, which are contrasted with the opinions of
clinicians belonging to the CF unit. There are also studies that
clearly show that clinical impressions are not accurate enough to
determine the real therapeutic adherence of patients, and so it
would be also convenient to use a more objective method
[8,15]. It has been mentioned that the level of adherence could
vary according to the subjectiveness of the method employed
such as with a personal questionnaire, even if the results are
corrected with the opinions of the medical professionals, or
other objective measures like blood serum levels or urinary
excretion of medications or their metabolites or monitorization
of adherence with electronic recording devices or dispensers of
medications [3–6,8,14,26]. Nevertheless these methods have
their own inconveniences [3]. With respect to drug levels in
serum or urine, we must emphasise that they are invasive
methods and may only represent yet another test for patients,
due to the several samples needed to check their compliance [3],
also to add the pharmacokinetic variations of the substance are
to be studied. Regarding electronic monitorization, the data
obtained only provides information about the use of a me-
dication dispenser, but not about whether the patient is actually
taking the medication removed from the dispenser, and that this
type of monitoring is still too expensive [3,26]. This could also
limit other evaluations concerning aspects such as diet, exercise
or physiotherapy [26].
Limitations of our study include a scarce number of patients
that attend our CF unit and so the large range of ages. Maybe
with a more ample number of patients we could obtain a more
significant result for other possible predictors of adherence.
Other questions which must probably be taken into account in
future studies, include psychological factors, the way patients
cope with their illness, the level of stress that it prompts, social
factors, relationships between patients and clinicians or other
clinical factors.
We can conclude that the overall treatment compliance is
similar to other studies, [3–7] with a tendency to overestimate
their treatment adherence compared to the opinion of their cli-
nician. There are differences in the level of adherence depending
upon the different types of treatments. Treatments which are
more followed by patients are those that they seem to believe to
have more repercussion in their quality of life and those they
consider as essential, observing in our study that digestive
medication is important on their list. However physiotherapy
seems to be deficient regarding the number of subjects and the
frequency they did it, explained by the extended patient belief
that they have little importance and repercussion on their quality
of life.
We have observed a decrease in therapeutic adherence with
age, longer time of evolution and severity of CF illness. There
seems to be no influence with respect to gender, nutritional
parameters, or pulmonary function data. The treatments mostly
appreciated and considered as more essential by patients, were
coincident with a higher level of treatment adherence,
emphasizing the need for a careful and continuous follow up
of patients.
Appendix A
Cystic Fibrosis compliance questionnaire
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